
Share
As healthcare fraud becomes more sophisticated, outdated payment integrity systems fall short, leaving health plans vulnerable to escalating overpayments and fraudulent claims.
Spring is a season of audits, renewals, and difficult conversations. For many health plans, one of these challenging discussions centers around their payment integrity vendor. A common refrain from industry leaders is, “We’ve been with them for years, and nothing’s really changed.” This sentiment underscores a critical issue: while the healthcare billing environment has evolved significantly, some payment integrity programs have not kept pace.
The gap between what health plans are paying and what they should be paying continues to widen. According to the U.S. Department of Health and Human Services, in 2025, $16.6 billion was reported in healthcare fraud, improper payments, and overpayments. This figure represents only what was identified and reported. Estimates suggest that traditional payment integrity solutions miss 20% or more of improper payments, leading to over $500 billion in unidentified losses for healthcare payers each year.
The numbers are staggering and cannot be ignored. Half a trillion dollars annually in unidentified losses is a significant financial burden that directly impacts health plans, inflates premiums for members, and strains vendor relationships. These figures translate into real-world consequences: higher costs for healthcare consumers and reduced efficiency for providers.
The forces driving these expenditures are intensifying. From 2021 to 2023, employer healthcare spending on pharmacy increased from 21% to 27%. Healthcare’s share of GDP continues to grow as medical inflation outpaces overall inflation. An aging population with more complex health needs is using increasingly expensive treatments, which adds to the billing complexity and creates more opportunities for errors, upcoding, and overpayment.

The global payment integrity market reached $8.26 billion in 2025 and is projected to grow to $34.82 billion by 2035, at a compound annual growth rate of 15.5%. This significant market expansion underscores the growing demand for more effective solutions. However, not all vendors are keeping up with this evolution.
For too long, payment integrity has been primarily reactive, focusing on catching errors after claims have been paid. This approach is no longer sufficient. Most payers are now shifting their strategies toward pre-payment review, identifying and correcting errors before claims finalize. This proactive approach helps protect the medical loss ratio and ensures that funds are used efficiently.
Investors should be aware of the critical role payment integrity plays in managing healthcare costs. Vendors who can demonstrate a commitment to innovation and a proactive approach will likely see stronger market positions and better financial performance. Conversely, those who fail to evolve may find themselves left behind as health plans seek more advanced solutions to combat fraud and overpayments.
In conclusion, the healthcare industry is at a pivotal moment in payment integrity. The stakes are high, and the consequences of inaction are severe. Health plans must critically evaluate their current vendors and consider whether they are equipped to meet the evolving demands of the market. For investors, this presents both risks and opportunities, with those who can identify and support forward-thinking vendors likely to see the best returns.
Tags
Original Sources
The Case for a More Proactive Payment Integrity Program
↗ https://www.fiercehealthcare.com/sponsored/your-payment-integrity-partner-shouldnt-be-problem
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
7 May 2026
133 articles
Related Articles
Related Articles
More Stories